BioLife Solutions
BLFS
132 hedge funds and large institutions have $1.24B invested in BioLife Solutions in 2021 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 56 increasing their positions, 34 reducing their positions, and 26 closing their positions.
191% more call options, than puts
Call options by funds: $2.99M | Put options by funds: $1.03M
65% more repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 34
36% more capital invested
Capital invested by funds: $915M → $1.24B (+$327M)
0% more funds holding
Funds holding: 132 → 132 (0)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 26
8.45% less ownership
Funds ownership: 77.63% → 69.18% (-8.5%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
+$20.8M |
| 2 |
BlackRock
New York
|
+$20.6M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12.1M |
| 4 |
ZDA
Zweig-DiMenna Associates
New York
|
+$10.7M |
| 5 |
State Street
Boston,
Massachusetts
|
+$7.73M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
THP
Tower House Partners
London,
United Kingdom
|
-$11M |
| 2 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
-$7.36M |
| 3 |
Russell Investments Group
London,
United Kingdom
|
-$6.09M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$5.43M |
| 5 |
RA
Royce & Associates
New York
|
-$4.1M |
BLFS Hedge Fund Activity: Q2 2021 in Review
132 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q2 2021, worth a combined $1.24B — up 36% from $915M a quarter earlier.
Fund positioning in BLFS was balanced in Q2 2021: 26 funds opened new positions, 26 closed out, 56 added to existing stakes and 34 trimmed.
The largest buyer was Marshall Wace, adding an estimated $20.8M. The largest seller was Tower House Partners, exiting entirely with an estimated $11M sold.
- 132 institutional investors held BioLife Solutions (BLFS) as of Q2 2021, unchanged from Q1 2021.
- Funds reported $1.24B of BioLife Solutions stock for Q2 2021, up 36% quarter-over-quarter.
- 26 funds opened new BioLife Solutions positions in Q2 2021 and 26 closed out, a net change of 0 holders.
- The largest BioLife Solutions buyer in Q2 2021 was Marshall Wace, an estimated $20.8M added.
- The largest BioLife Solutions seller in Q2 2021 was Tower House Partners, an estimated $11M sold.
Based on aggregated 13F filings for Q2 2021.